Glutamine in the intensive care unit

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 1, 2014, Pages 98-104

  Cynober, Luc ^a,b   De Bandt, Jean Pascal ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b Faculty of Pharmacy   (France)

Author keywords

Glutamine; Intensive care; Metabolism; Supplementation

Indexed keywords

GLUTAMINE;

CRITICALLY ILL PATIENT; DIET SUPPLEMENTATION; ENTERIC FEEDING; EXPERIMENTAL STUDY; HUMAN; INJURY; INTENSIVE CARE; INTENSIVE CARE UNIT; NUTRITION; PRACTICE GUIDELINE; REVIEW; RISK FACTOR;

CRITICAL ILLNESS; DIETARY SUPPLEMENTS; ENTERAL NUTRITION; EVIDENCE-BASED MEDICINE; GLUTAMINE; HUMANS; INTENSIVE CARE UNITS; LIVER FAILURE; META-ANALYSIS AS TOPIC; PARENTERAL NUTRITION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY;

EID: 84890992913     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000014     Document Type: Review

References (25)

1. Sacks GS. Effect of glutamine-supplemented parenteral nutrition on mortality in critically ill patients. Nutr Clin Pract 2011; 26: 44-47.
2. Tung JN, Lee WY, Pai MH, et al. Glutamine modulates CD8aa+ TCRab+ intestinal intraepithelial lymphocyte expression in mice with polymicrobial sepsis. Nutrition 2013; 29: 911-917.
3. Lee WY, Hu YM, Ko TL, et al. Glutamine modulates sepsis-induced changes to intestinal intraepithelial gdT lymphocyte expression in mice. Shock 2012; 38: 288-293.
4. Lehmann C, Pavlovic D, Zhou J, et al. Intravenous free and dipeptide-bound glutamine maintains intestinal microcirculation in experimental endotoxemia. Nutrition 2012; 28: 588-593.
5. Hu YM, Pai MH, Yeh CL, et al. Glutamine administration ameliorates sepsisinduced kidney injury by down regulating the high-mobility group box protein- 1-mediated pathway in mice. Am J Physiol Renal Physiol 2012; 302:F150- F158.
6. Hou YC, Pai MH, Liu JJ, Yeh SL. Alanyl-glutamine resolves lipopolysaccharide- induced lung injury in mice by modulating the polarization of regulatory T cells and T helper 17 cells. J Nutr Biochem 2013; 24: 1555-1563.
7. Boutry C, Matsumoto H, Bos C, et al. Decreased glutamate, glutamine and citrulline concentrations in plasma and muscle in endotoxemia cannot be reversed by glutamate or glutamine supplementation: a primary intestinal defect? Amino Acids 2012; 43: 1485-1498.
8. Kao CC, Hsu JW, Bandi V, Jahoor F. Alterations in glutamine metabolism and its conversion to citrulline in sepsis. Am J Physiol Endocrinol Metab 2013; 304:E1359-E1364. Data presented in this study may be important for a better understanding of the mechanisms of increased nitrogen loss in sepsis.
9. Cynober L. Amino acid metabolism. In: Lennarz WJ, Lane MD, editors. Encyclopedia of biological chemistry. New York: Elsevier; 2013. pp. 91-96.
10. Andrews PJD, Avenell A, Noble DB, et al. Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients. BMJ 2011; 342:d1542.
11. Bollhalder L, Pfeil AM, Tomonaga Y, Schwenkglenks M. A systematic literature review and meta-analysis of randomized clinical trials of parenteral glutamine supplementation. Clin Nutr 2013; 32: 213-223. This meta-analysis seeks to explain why GLN effects on ICU patients are less demonstrative than previously thought in relation to the inclusion of recent multicenter trials.
12. Grau T, Bonet A, Minambres E, et al. The effect of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious morbidity and insulin sensitivity in critically ill patients. Crit Care Med 2011; 39: 1263-1268.
13. Wernerman J, Kirketeig T, Andersson B, et al. Scandinavian glutamine trial: a pragmatic multicentre randomised clinical trial of intensive care unit patients. Acta Anaesthesiol Scand 2011; 55: 812-818.
14. Çekmen N, Aydin A, Erdemli Ö. The impact of L-alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on clinical outcome in critically patients. e-SPEN 2011; 6:e64-e67.
15. Lin JJ, Chung XJ, Yang CY, Lau HL. A meta-analysis of trials using the intention to treat principle for glutamine supplementation in critically ill patients with burn. Burns 2013; 39: 565-570.
16. Cavalcante AAM, Campelo MWS, De Vasconcelos MPP, et al. Enteral nutrition supplemented with L-glutamine in patients with systemic inflammatory response syndrome due to pulmonary infection. Nutrition 2012; 28: 397-402.
17. Heyland D, Muscedere J, Wischmeyer PE, et al. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med 2013; 368: 1489-1497. The largest trial on GLN supplementation in ICU patients. However, multiple organ failure is probably not an appropriate indication for GLN supplementation. Also, included patients seem very heterogeneous.
18. Bistrian BR. Glutamine and antioxidants in critically ill patients. N Engl J Med 2013; 369:482. [Letter]
19. Heyland DK, Dhaliwal R. Role of glutamine supplementation in critical illness given the results of the REDOXS study. JPEN J Parenter Enteral Nutr 2013; 37: 442-443.
20. Van den Berghe G. Low glutamine levels during critical illness: adaptive or maladaptive? N Engl J Med 2013; 368: 1549-1550. [Letter]
21. Rousseau AF, Losser MR, Ichai C, et al. ESPEN endorsed recommendations: nutritional therapy in major burns. Clin Nutr 2013; 32: 497-502.
22. Buijs NB, Vermeulen MAR, Van Leeuwen PAM. Glutamine and antioxidants in critically ill patients [letter]. N Engl J Med 2013; 369:483. [Letter]
23. Vanek VW, Matarese LE, Robinson M, et al. ASPEN position paper: parenteral nutrition glutamine supplementation. Nutr Clin Pract 2011; 26: 479-494.
24. Rodas PC, Rooyackers O, Hebert C, et al. Glutamine and glutathione at ICU admission in relation to outcome. Clin Sci 2012; 122: 591-597. This study extends the previous data showing that low plasmaGLN is a predictor of mortality in ICU patients. It further shows that high GLN levels are also associated with poor prognosis, probably in relation to liver failure.
25. Gottshalk A, Wempe C, Goeters C. Glutamine in the ICU: who needs supply? Clin Nutr 2013; 32: 668-669. This study shows that high GLN levels are associated with morbi-mortality in ICU patients. GLN should not be supplied in such patients.